通过专为投资者打造的一站式数据看板，全面查看 Xilio Therapeutics Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图，助您更轻松地进行财务分析。您可以查看最新年度财务报告，也可以通过利润表、资产负债表和现金流量表，按季度分析公司表现。借助实时财务指标，持续追踪公司的经营状况和市场表现更加便捷。

关键财务比率

总市值

53.46M

股息TTM

0.00

市盈率 TTM

-0.16

每股收益TTM

-56.76

营业收入

43.77M

净利润

-58.24M

净资产收益率

-75.20%

总资产收益率

-23.43%

Xilio Therapeutics Inc 财报日历

财务报表摘要

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

财务指标

每股收益

-99.92%-0.33

-228.25%-0.58

571.65%0.95

48.84%-0.11

31.86%-0.16

71.19%-0.18

68.44%-0.20

63.70%-0.22

65.79%-0.24

25.34%-0.62

21.82%-0.64

---0.61

---0.70

---0.83

---0.82

---2.40

----

营业收入

131.22%18.69M

331.67%12.65M

693.85%13.69M

742.51%19.07M

242.98%8.08M

--2.93M

--1.72M

--2.26M

--2.36M

----

净利润

59.78%-6.37M

28.16%-9.53M

179.13%10.36M

-16.17%-16.29M

-13.78%-15.84M

22.89%-13.27M

25.84%-13.09M

16.29%-14.02M

28.05%-13.93M

24.04%-17.20M

21.41%-17.66M

15.37%-16.75M

21.36%-19.36M

-6.06%-22.65M

-14.03%-22.47M

-21.78%-19.79M

-6.18%-24.61M

-28.12%-21.35M

5.16%-19.70M

-9.66%-16.25M

利润率

82.60%-34.09%

83.36%-75.34%

109.97%75.70%

86.21%-85.42%

66.83%-195.99%

---452.73%

---759.45%

---619.53%

---590.79%

----

毛利率

0.00%100.00%

--100.00%

----

资产负债率

----

-100.00%0.00%

----

-100.00%0.00%

-22.99%5.44%

--6.37%

--7.74%

--7.37%

--7.06%

--6.21%

----

利润表

营业收入

131.22%18.69M

331.67%12.65M

693.85%13.69M

742.51%19.07M

242.98%8.08M

--2.93M

--1.72M

--2.26M

--2.36M

----

营业利润

75.70%-3.49M

-1.88%-14.11M

13.16%-11.84M

86.97%-1.93M

2.10%-14.37M

16.25%-13.85M

24.83%-13.63M

14.73%-14.80M

27.05%-14.67M

29.70%-16.54M

21.74%-18.13M

14.08%-17.36M

18.07%-20.12M

-10.85%-23.53M

-18.46%-23.17M

-26.60%-20.21M

-6.72%-24.55M

-28.47%-21.22M

5.04%-19.56M

-9.15%-15.96M

净利润

59.78%-6.37M

28.16%-9.53M

179.13%10.36M

-16.17%-16.29M

-13.78%-15.84M

22.89%-13.27M

25.84%-13.09M

16.29%-14.02M

28.05%-13.93M

24.04%-17.20M

21.41%-17.66M

15.37%-16.75M

21.36%-19.36M

-6.06%-22.65M

-14.03%-22.47M

-21.78%-19.79M

-6.18%-24.61M

-28.12%-21.35M

5.16%-19.70M

-9.66%-16.25M

资产负债表

流动资产

17.58%145.47M

65.46%154.21M

140.77%145.03M

96.01%124.09M

58.59%123.72M

34.71%93.20M

25.16%60.23M

-1.82%63.31M

-0.53%78.01M

-28.66%69.19M

-61.34%48.13M

-54.69%64.48M

-51.89%78.42M

-46.45%96.98M

-38.53%124.50M

34.80%142.31M

30.84%163.01M

26.97%181.09M

--202.52M

--105.57M

流动负债总额

-35.79%34.20M

-9.82%42.96M

106.42%56.27M

48.34%56.40M

37.83%53.26M

50.84%47.64M

70.84%27.26M

124.60%38.02M

137.16%38.64M

95.02%31.58M

-24.44%15.96M

0.52%16.93M

-8.31%16.29M

32.47%16.19M

65.28%21.12M

30.85%16.84M

-16.59%17.77M

-24.97%12.22M

--12.78M

--12.87M

总资产

15.28%154.25M

57.63%163.49M

117.64%154.69M

79.08%133.69M

48.89%133.81M

25.55%103.72M

16.66%71.08M

-4.09%74.66M

-2.69%89.87M

-25.91%82.61M

-56.22%60.93M

-50.55%77.84M

-48.15%92.36M

-43.21%111.50M

-36.18%139.16M

30.39%157.41M

27.21%178.13M

24.00%196.35M

--218.06M

--120.72M

总负债

-35.31%81.99M

-2.23%90.94M

123.30%119.41M

164.12%141.79M

124.50%126.74M

63.63%93.02M

121.91%53.48M

111.82%53.68M

125.99%56.46M

112.80%56.84M

-28.10%24.10M

-18.55%25.34M

-26.33%24.98M

-11.64%26.71M

2.72%33.52M

-9.26%31.12M

-11.80%33.91M

-12.60%30.23M

--32.63M

--34.29M

总权益

922.27%72.26M

577.99%72.55M

100.44%35.27M

-138.60%-8.10M

-78.85%7.07M

-58.47%10.70M

-52.21%17.60M

-60.05%20.97M

-50.40%33.42M

-69.61%25.77M

-65.14%36.83M

-58.43%52.50M

-53.28%67.38M

-48.96%84.79M

-43.03%105.65M

46.12%126.30M

41.98%144.22M

34.24%166.12M

--185.43M

--86.43M

现金流量表

经营净额

-29.60%-18.76M

-177.10%-22.34M

85.89%-2.00M

-27.96%-17.50M

-172.56%-14.48M

375.93%28.98M

-5.44%-14.16M

-2.27%-13.67M

220.39%19.95M

58.41%-10.50M

26.32%-13.43M

32.85%-13.37M

1.09%-16.57M

-21.19%-25.25M

-6.18%-18.22M

3.91%-19.91M

16.79%-16.76M

8.35%-20.84M

-35.08%-17.16M

-98.06%-20.72M

投资净额

95.26%-19.00K

-2427.27%-556.00K

-1483.33%-95.00K

100.00%0.00

-1809.52%-401.00K

---22.00K

---6.00K

---9.00K

93.35%-21.00K

100.00%0.00

59.01%-316.00K

33.07%-170.00K

-34.66%-509.00K

-192.11%-333.00K

-76.03%-771.00K

-49.41%-254.00K

-250.00%-378.00K

80.14%-114.00K

融资净额

-90.51%4.49M

638.97%35.71M

337.28%35.87M

-9400.00%-285.00K

136.30%47.36M

406.50%4.83M

601.96%8.20M

99.87%-3.00K

2120.46%20.04M

156.52%954.00K

-7680.95%-1.63M

-10063.64%-2.24M

-4623.81%-992.00K

-33660.00%-1.69M

-100.02%-21.00K

-107.31%-22.00K

93.98%-21.00K

-100.00%-5.00K

92560.80%115.83M

563.08%301.00K

营业收入

业务

报告期:

暂无数据

地区

报告期:

暂无数据

常见问题

Xilio Therapeutics Inc的总收入是多少？



根据Xilio Therapeutics Inc的FY2025财报，总收入达到了43.77M（同比变化6.34M）。

Xilio Therapeutics Inc的流动资产是多少？



根据Xilio Therapeutics Inc的FY2025财报，流动资产为145.03M（同比变化140.77）。

Xilio Therapeutics Inc的总资产是多少？



根据Xilio Therapeutics Inc的FY2025财报，Xilio Therapeutics Inc的总资产为154.69M（同比变化117.64）。

Xilio Therapeutics Inc的总负债是多少？



根据Xilio Therapeutics Inc的FY2025财报，Xilio Therapeutics Inc的总负债为119.41M（同比变化123.30）。

Xilio Therapeutics Inc的总权益是多少？



根据Xilio Therapeutics Inc的FY2025财报，Xilio Therapeutics Inc的总权益为35.27M（同比变化100.44）。

Xilio Therapeutics Inc的净营业收入是多少？



根据Xilio Therapeutics Inc的FY2025财报，Xilio Therapeutics Inc的净营业收入为-41.98M（同比变化29.61）。

Xilio Therapeutics Inc的净投资是多少？



根据Xilio Therapeutics Inc的FY2025财报，Xilio Therapeutics Inc的净投资为-518.00K（同比变化-1338.89）。

Xilio Therapeutics Inc的净融资是多少？



根据Xilio Therapeutics Inc的FY2025财报，Xilio Therapeutics Inc的净融资为87.78M（同比变化200.64）。

Xilio Therapeutics Inc的每股收益（EPS）是多少？



根据Xilio Therapeutics Inc的FY2025财报，每股收益（EPS）为-4.19（同比变化72.49）。

Xilio Therapeutics Inc的净利润是多少？



根据Xilio Therapeutics Inc的FY2025财报，净利润为-35.04M（同比变化39.84）。

Xilio Therapeutics Inc的净利润率是多少？



根据Xilio Therapeutics Inc的FY2025财报，净利润率为-80.05（同比变化91.28）。

Xilio Therapeutics Inc的股东权益回报率（ROE）是多少？



根据Xilio Therapeutics Inc的FY2025财报，股东权益回报率（ROE）为-132.53（同比变化38.07）。

Xilio Therapeutics Inc的资产回报率（ROA）是多少？



根据Xilio Therapeutics Inc的FY2025财报，资产回报率（ROA）为-31.04（同比变化64.83）。

Xilio Therapeutics Inc的营业利润是多少？



根据Xilio Therapeutics Inc的FY2025财报，营业利润为-41.98M（同比变化29.61）。